Faron Pharmaceuticals Oy

FPHAF · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$9,503$6,875$6,990$6,853
Short-Term Investments$0$0$0$0
Receivables$201$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$1,361$1,993$2,740$5,170
Total Curr. Assets$11,065$8,868$9,730$12,023
Property Plant & Equip (Net)$298$204$327$207
Goodwill$0$0$0$0
Intangibles$1,113$1,088$1,154$899
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$45$60$60$53
Total NC Assets$1,456$1,352$1,541$1,159
Other Assets$0$0$0$0
Total Assets$12,521$10,220$11,271$13,182
Liabilities
Payables$4,876$8,971$5,142$2,229
Short-Term Debt$3,839$3,638$2,004$613
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$2,859
Other Curr. Liab.$1,456$2,403$3,325$4,336
Total Curr. Liab.$10,171$15,012$10,471$7,178
LT Debt$8,274$9,473$11,265$2,934
Deferred Rev, NC$0$0$0$151
Deferred Tax Liab, NC$0$0$0-$151
Other NC Liab.$3,838$896$1,011$1
Total NC Liab.$12,112$10,369$12,276$3,086
Other Liabilities$0$0$0$0
Cap. Leases$303$213$316$200
Total Liabilities$22,283$25,381$22,747$10,264
Equity
Pref Stock$0$0$0$0
Common Stock$2,691$2,691$2,691$2,691
Retained Earnings-$197,421-$172,208-$143,713-$116,265
AOCI$0$154$130$116,493
Other Equity$184,968$154,202$129,416-$1
Total Equity-$9,762-$15,161-$11,476$2,918
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$12,521$10,220$11,271$13,182
Net Debt$2,610$6,236$6,279-$3,306